Every Form 4 that Clearfield (CLFD) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CLFD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CLFD filings page.
Clearfield, Inc. Chief Executive Officer Cheryl Beranek reported an open-market sale of 1,778 shares of Clearfield common stock. The shares were sold on July 1, 2026 at a weighted average price of $40.06 per share, in multiple trades between $40.00 and $40.25.
The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Beranek on December 15, 2025. Following this sale, she continues to hold 492,973 shares of Clearfield common stock directly.
Clearfield, Inc. Chief Financial Officer Daniel R. Herzog acquired additional company stock through the employee stock purchase plan. He obtained 752 shares of common stock labeled as "Common Stock (ESPP)" at a price of $24.78 per share, based on 85% of the closing price on December 31, 2025 for the purchase period from January 1 to June 30, 2026. Following this plan-related acquisition, he directly owns 85,834 shares of Clearfield common stock.
Clearfield, Inc. Chief Commercial Officer Anis Khemakhem acquired 158 shares of Common Stock through the company’s Employee Stock Purchase Plan. The shares were purchased for $24.78 per share, based on 85% of the closing price on December 31, 2025, for the ESPP period from January 1 to June 30, 2026. Following this routine compensation-related acquisition, Khemakhem directly holds 25,284 Common Stock shares.
Clearfield, Inc. Chief Operating Officer John P. Hill reported an acquisition of company stock through an employee plan. On June 30, 2026, he acquired 459 shares of common stock at $24.78 per share under the Employee Stock Purchase Plan for the January 1–June 30, 2026 period.
The footnote explains these shares were purchased at 85% of the December 31, 2025 closing price, consistent with the plan’s terms. Following this transaction, Hill directly owns 192,674 shares of Clearfield common stock.
Clearfield, Inc. Chief Executive Officer Cheryl Beranek acquired 210 shares of common stock through the company’s Employee Stock Purchase Plan. The shares were recorded at $24.78 per share, based on 85% of the closing price on December 31, 2025. Following this compensation-related acquisition, she directly holds 494,751 shares of Clearfield common stock.
Clearfield, Inc.'s Chief Commercial Officer Anis Khemakhem reported an open-market sale of 1,684 shares of common stock on June 9, 2026, at a weighted average price of $39.90 per share. After this transaction, he directly holds 25,126 Clearfield shares.
Clearfield, Inc. Chief Executive Officer Cheryl Beranek reported an open-market sale of 7,500 shares of Common Stock on June 1, 2026, at a weighted average price of $46.92 per share.
The trades were executed under a Rule 10b5-1 trading plan adopted on December 15, 2025, and occurred at prices ranging from $46.31 to $47.25. Following this sale, Beranek directly holds 494,541 shares of Clearfield common stock.
Clearfield, Inc. Chief Executive Officer Cheryl Beranek reported an open-market sale of 2,500 shares of the company’s Common Stock at $50.00 per share on May 27, 2026. After this transaction, she directly holds 502,041 shares. The footnote states the sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on December 15, 2025, indicating it was scheduled in advance as part of a trading program.
Clearfield, Inc. Chief Executive Officer Cheryl Beranek reported open-market sales of a total of 7,500 shares of Common Stock. She sold 5,000 shares at a weighted average price of $40.27 per share and 2,500 shares at a weighted average price of $45.02 per share. These transactions were executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on December 15, 2025. Following the sales, Beranek directly holds 504,541 shares of Clearfield common stock.
Clearfield, Inc. director Walter Louis Jones Jr reported an open-market sale of Common Stock. On May 11, 2026, he sold 2,391 shares at $46.05 per share. After this transaction, he directly holds 8,682 shares of Clearfield common stock.
Clearfield, Inc.’s Chief Commercial Officer, Anis Khemakhem, reported a routine tax-related share disposition. On May 6, 2026, 635 shares of common stock were withheld at $30.28 per share to cover taxes upon vesting of restricted stock granted on May 9, 2024.
Following this tax-withholding transaction, Khemakhem directly holds 26,810 shares of Clearfield common stock. This was not an open-market sale but a standard mechanism to satisfy tax obligations tied to equity compensation.
Clearfield, Inc. director Carol Ann Wirsbinski reported an award of 2,544 shares of common stock. The shares were acquired at a stated price of $0.00 per share as a grant, not an open-market purchase, bringing her directly held total to 9,631 shares.
According to the filing, restrictions on this restricted stock lapse on the first business day prior to Clearfield’s 2027 Annual Meeting of Shareholders, meaning the shares will remain subject to vesting conditions until that time.
Kelly Catherine T. reported acquisition or exercise transactions in this Form 4 filing.
Clearfield, Inc. director Kelly Catherine T. received a grant of 2,544 shares of common stock at no cost. After this award, she directly holds 5,317 shares. The filing notes that restrictions on this restricted stock lapse on the first business day prior to the 2027 Annual Meeting of Shareholders.
Jones Walter Louis JR reported acquisition or exercise transactions in this Form 4 filing.
Clearfield, Inc. director Walter Louis Jones Jr. reported an equity award of 2,544 shares of common stock, received at a price of $0.0000 per share. After this grant, he directly holds 11,073 common shares.
According to the filing, restrictions on this restricted stock lapse on the first business day before the company’s 2027 Annual Meeting of Shareholders, meaning the award remains subject to holding conditions until that time.
Sarcevic Ademir reported acquisition or exercise transactions in this Form 4 filing.
Clearfield, Inc. director Ademir Sarcevic received a grant of 2,544 shares of common stock with a stated price of $0.0000 per share. Following this award, his directly owned holdings increased to 5,317 shares. Restrictions on this restricted stock lapse on the first business day prior to the 2027 Annual Meeting of Shareholders.
Clearfield, Inc. director Kathleen Skarvan reported receiving a grant of 2,544 shares of common stock on February 27, 2026 as a stock award. The shares were acquired at a stated price of $0.0000 per share, so no cash was paid for the grant.
Following this award, she directly owns 2,870 shares of Clearfield common stock. The filing notes that restrictions on this restricted stock will lapse on the first business day prior to the 2027 Annual Meeting of Shareholders, meaning the shares are subject to holding conditions until that time.
ROTH RONALD G reported acquisition or exercise transactions in this Form 4 filing.
Clearfield, Inc. director and 10% owner Ronald G. Roth reported an award of 2,544 shares of common stock on February 27, 2026, at a stated price of $0.00 per share. These shares are restricted stock, with restrictions scheduled to lapse on the first business day prior to the 2027 Annual Meeting of Shareholders.
After this grant, Roth directly owns 1,281,808 common shares. In addition, 176,760 common shares are held indirectly through his spouse, as disclosed in the filing.
Clearfield, Inc. director Rebecca Seidel reported an award of 2,544 shares of common stock. These shares were acquired as a grant at a price of $0.00 per share, increasing her directly held stake to 2,870 shares of common stock.
The award consists of restricted stock, meaning it is subject to vesting conditions. According to the terms, the restrictions on this restricted stock will lapse on the first business day prior to the company’s 2027 Annual Meeting of Shareholders, after which the shares will be fully vested.
Clearfield, Inc. director Donald R. Hayward reported an open-market sale of company stock. On February 19, 2026, he sold 3,595 shares of Clearfield common stock at a weighted average price of about $32.00 per share, with individual trade prices ranging from $32.00 to $32.06. After this transaction, he directly holds 10,870 shares of Clearfield common stock.
Clearfield, Inc. insider Ronald G. Roth, the company’s chairman of the board and a 10% owner, reported buying 10,000 shares of common stock on December 15, 2025. The trade was coded as a purchase at a weighted-average price of $30.06 per share, with individual transactions occurring between $29.85 and $30.25.
After this transaction, Roth beneficially owns 1,279,264 Clearfield shares directly, plus an additional 176,760 shares held indirectly through his spouse.
Clearfield, Inc. director and chief executive officer Cheryl Beranek reported a disposition of 1,960 shares of Clearfield common stock on 12/11/2025 in a transaction coded "G" at a price of $0 per share.
After this transaction, she directly beneficially owns 511,831 shares of Clearfield common stock.
Clearfield, Inc. reported that one of its directors acquired 326 shares of its common stock on 12/10/2025. The shares were acquired at a stated price of $0, indicating they were granted as equity compensation rather than bought in the market. After this grant, the director beneficially owns 326 shares directly. The restrictions on these shares lapse on the one-year anniversary of the grant date, so the stock becomes fully available only after that vesting period.
Clearfield, Inc. director Kathleen Skarvan reported acquiring 326 shares of Clearfield common stock on 12/10/2025. The shares were acquired at a price of $0 per share, resulting in 326 shares beneficially owned after the transaction, all held as direct ownership. The filing notes that restrictions on these shares lapse on the one-year anniversary of the grant date.
Clearfield, Inc. (CLFD) reported a Form 4 for its Chief Operating Officer, reflecting equity awards tied to performance stock units. On 11/20/2025, the officer received 5,393 shares of common stock and 10,788 shares of restricted stock at a stated price of $0 per share upon vesting of performance-based awards.
The restricted stock is scheduled to vest in two equal installments on November 16, 2026 and November 16, 2027. To cover taxes on the vesting, 2,653 shares of common stock were withheld at a price of $28.22 per share. Following these transactions, the officer directly holds common and restricted shares in Clearfield, aligning compensation with company performance.
Clearfield, Inc. (CLFD) reported insider equity activity for its Chief Financial Officer, Daniel Herzog, on 11/20/2025. The filing shows the vesting of performance-based awards and related tax withholding.
Herzog acquired 2,696 shares of common stock at $0 per share upon vesting of performance stock units and 5,394 shares of restricted stock at $0 per share from the same performance awards. The restricted stock is scheduled to vest in two equal installments on November 16, 2026 and November 16, 2027.
To cover taxes on the vesting of one-third of the performance stock units, 824 shares of common stock were withheld at a price of $28.22 per share. After these transactions, Herzog beneficially owned 73,499 shares of common stock and 74,323 shares of restricted stock, all held directly.
Clearfield, Inc. (CLFD) reported an insider equity transaction for its Chief Executive Officer and director, Cheryl Beranek. On 11/20/2025, she acquired 5,393 shares of common stock at $0 per share upon the vesting of performance stock units, increasing her directly held common shares to 480,111.
On the same date, she also received 10,788 shares of restricted stock at $0 per share upon the vesting of performance stock units, bringing her restricted stock holdings to 490,899 shares. The restricted stock is scheduled to vest in two equal installments on November 16, 2026 and November 16, 2027.
To cover taxes on vesting, 2,653 shares of common stock were disposed of at $28.22 per share through share withholding, leaving Beranek with 488,246 shares of common stock held directly after the reported transactions.
Clearfield, Inc. (CLFD) reported an amended Form 4 for its Chief Financial Officer, who is an officer of the company. On 11/16/2025, a total of 510, 973, and 825 shares of common stock were withheld at a price of $30.72 per share to cover taxes due upon vesting of three restricted stock grants.
The tax-withholding relates to restricted stock originally granted on February 24, 2023, November 16, 2023, and November 26, 2024. After these transactions, the CFO beneficially owns 66,233 shares of Clearfield common stock. The amendment corrects an earlier filing from 11/19/2025 to show these withheld restricted stock shares as shares disposed of rather than acquired.
Clearfield, Inc. (CLFD) reported insider activity by its Chief Financial Officer on a Form 4. On 11/16/2025, the officer reported three transactions in Clearfield common stock coded as tax-related events tied to restricted stock vesting. The transactions involved 510, 973, and 825 shares of common stock at a price of $30.72 per share, as shown in the table.
According to the filing notes, these transactions reflect payment of taxes by withholding shares upon vesting of restricted stock granted on February 24, 2023, November 16, 2023, and November 26, 2024. Following the reported activity, the officer directly beneficially owned 66,233 shares of Clearfield common stock.
Clearfield, Inc. (CLFD) reported insider equity activity by its Chief Executive Officer and Director, Cheryl Beranek, in a Form 4. On 11/16/2025, the reporting person had shares of Clearfield common stock withheld to cover tax obligations upon the vesting of previously granted restricted stock awards. Three tax-withholding transactions were reported, each coded as an "F" transaction: 1,020, 1,948, and 2,318 shares of common stock, all at a price of $30.72 per share.
After these tax-related withholdings, the reporting person directly beneficially owned 474,718 shares of Clearfield common stock. The explanations clarify that each transaction related to the vesting of 33% installments of restricted stock granted on February 24, 2023, November 16, 2023, and November 26, 2024, respectively. These are routine equity compensation and tax-settlement events for a senior executive.
Clearfield, Inc. (CLFD) insider activity: Chief Operating Officer John P. Hill reported routine share-withholding transactions related to restricted stock vesting. On 11/16/2025, the company withheld 1,020, 2,017 and 2,653 shares of Clearfield common stock at a price of $30.72 per share to cover tax obligations as different 33% tranches of prior restricted stock grants vested. After these tax-withholding transactions, Hill directly beneficially owns 161,435 shares of Clearfield common stock.
John P. Hill, Chief Operating Officer and director of Clearfield, Inc. (CLFD), reported option exercises and subsequent share dispositions on 09/18/2025. He exercised 17,776 options with an exercise price of $23.74 and 24,000 options with an exercise price of $12.43, increasing beneficial ownership to 180,520 shares at one point. He also disposed of 14,000 shares and 13,395 shares by sale at $34.21 per share, leaving a reported beneficial ownership of 167,125 shares. The filings note the exercises occurred because the options were approaching expiration dates in November 2025. The Form 4 was signed by power of attorney on 09/22/2025.